BRPI0715123A2 - tratamento de disfunÇço endàcrina usando quelantes de ferro - Google Patents
tratamento de disfunÇço endàcrina usando quelantes de ferro Download PDFInfo
- Publication number
- BRPI0715123A2 BRPI0715123A2 BRPI0715123-3A BRPI0715123A BRPI0715123A2 BR PI0715123 A2 BRPI0715123 A2 BR PI0715123A2 BR PI0715123 A BRPI0715123 A BR PI0715123A BR PI0715123 A2 BRPI0715123 A2 BR PI0715123A2
- Authority
- BR
- Brazil
- Prior art keywords
- lower alkyl
- iron
- deferoxamine
- endocrine
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06118491 | 2006-08-04 | ||
EP06118491.7 | 2006-08-04 | ||
PCT/EP2007/006903 WO2008015021A1 (en) | 2006-08-04 | 2007-08-03 | Treatment of endocrine dysfunction using iron chelators |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0715123A2 true BRPI0715123A2 (pt) | 2013-06-04 |
Family
ID=37594962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0715123-3A BRPI0715123A2 (pt) | 2006-08-04 | 2007-08-03 | tratamento de disfunÇço endàcrina usando quelantes de ferro |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100004303A1 (de) |
EP (2) | EP2191829A3 (de) |
JP (1) | JP2009545547A (de) |
KR (1) | KR20090035737A (de) |
CN (1) | CN101500561A (de) |
AU (1) | AU2007280639A1 (de) |
BR (1) | BRPI0715123A2 (de) |
CA (1) | CA2659161A1 (de) |
MX (1) | MX2009001290A (de) |
RU (1) | RU2009107487A (de) |
WO (1) | WO2008015021A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8829198B2 (en) | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
CA2685043A1 (en) * | 2007-05-14 | 2008-11-20 | Novartis Ag | Use of iron chelator for the treatment of myocardial infarction |
WO2009055863A1 (en) * | 2007-11-01 | 2009-05-07 | The University Of Sydney | Desferrioxamine conjugates, derivatives and analogues |
WO2009111611A2 (en) | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
WO2010143006A1 (en) * | 2009-06-10 | 2010-12-16 | Carlo Ghisalberti | Orally bioavailable iron chelators in the treatment of an inflammatory bowel disease |
EP2780012A4 (de) * | 2011-11-18 | 2015-07-29 | Apotex Technologies Inc | Behandlungsverfahren mit deferipron |
CN102603964B (zh) * | 2012-01-15 | 2014-03-05 | 浙江工商大学 | 水溶性聚合物铁螯合剂及其制备方法和用途 |
AU2019255355A1 (en) * | 2018-04-15 | 2020-11-12 | Mordechai Chevion | Compositions and methods for treatment of iron overload |
KR102674622B1 (ko) * | 2021-10-15 | 2024-06-11 | 아주대학교산학협력단 | 데페록사민을 포함하는 근감소증의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY129541A (en) * | 1996-06-25 | 2007-04-30 | Novartis Ag | Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
CA2505476C (en) * | 2002-11-07 | 2015-05-26 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
EP1755579A4 (de) * | 2004-05-24 | 2009-06-10 | Univ New York | Verfahren zur behandlung oder prävention von pathologischen wirkungen einer akuten zunahme von hyperglykämie und/oder einer akuten zunahme von freiem fettsäurefluss |
EP1819334A1 (de) * | 2004-11-19 | 2007-08-22 | Shiva Biomedical, LLC | Verfahren zur behandlung von erythropoietin-resistenz |
US20070014764A1 (en) * | 2005-07-18 | 2007-01-18 | Andrew Levy | Reduction in myocardial infarction size |
-
2007
- 2007-08-03 CA CA002659161A patent/CA2659161A1/en not_active Abandoned
- 2007-08-03 US US12/375,547 patent/US20100004303A1/en not_active Abandoned
- 2007-08-03 RU RU2009107487/15A patent/RU2009107487A/ru not_active Application Discontinuation
- 2007-08-03 MX MX2009001290A patent/MX2009001290A/es unknown
- 2007-08-03 WO PCT/EP2007/006903 patent/WO2008015021A1/en active Application Filing
- 2007-08-03 EP EP09176308A patent/EP2191829A3/de not_active Withdrawn
- 2007-08-03 BR BRPI0715123-3A patent/BRPI0715123A2/pt not_active IP Right Cessation
- 2007-08-03 JP JP2009522184A patent/JP2009545547A/ja active Pending
- 2007-08-03 CN CNA200780030218XA patent/CN101500561A/zh active Pending
- 2007-08-03 EP EP07786560A patent/EP2049108A1/de not_active Withdrawn
- 2007-08-03 AU AU2007280639A patent/AU2007280639A1/en not_active Abandoned
- 2007-08-03 KR KR1020097004475A patent/KR20090035737A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008015021A1 (en) | 2008-02-07 |
RU2009107487A (ru) | 2010-09-10 |
MX2009001290A (es) | 2009-02-11 |
EP2049108A1 (de) | 2009-04-22 |
CN101500561A (zh) | 2009-08-05 |
AU2007280639A1 (en) | 2008-02-07 |
EP2191829A3 (de) | 2010-08-25 |
CA2659161A1 (en) | 2008-02-07 |
KR20090035737A (ko) | 2009-04-10 |
EP2191829A2 (de) | 2010-06-02 |
US20100004303A1 (en) | 2010-01-07 |
JP2009545547A (ja) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0715123A2 (pt) | tratamento de disfunÇço endàcrina usando quelantes de ferro | |
ES2718047T3 (es) | Triterpenoides sintéticos y métodos de uso en el tratamiento de la enfermedad | |
Pieper | Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction | |
JP7416872B2 (ja) | 癌の治療のための配合剤 | |
RU2264811C2 (ru) | Применение гипогликемического агента для лечения нарушенного метаболизма глюкозы | |
RU2684106C2 (ru) | Фармацевтические комбинации | |
Pootrakul et al. | Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand | |
Metzgeroth et al. | Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study | |
Prabhu et al. | Iron overload in beta thalassemia: a review | |
EP2359828A1 (de) | HDAC-Inhibitoren und auf Hormone zielende Arzneimittel zur Krebsbenhandlung | |
CN108697678A (zh) | sGC刺激剂在非酒精性脂肪性肝炎(NASH)治疗中的应用 | |
PT719143E (pt) | Utilizacao de derivados de tiazolidinodiona e agentes anti-hiperglicemicos relacionados no tratamento de patologias em risco de evoluir para diabetes mellitus nao-insulino-dependente | |
Bernhardt | Coordination chemistry and biology of chelators for the treatment of iron overload disorders | |
JP2010536880A (ja) | 糖尿病の合併症のための療法 | |
CA2878819A1 (en) | Tri-salt form of metformin | |
Kwiatkowski | Oral iron chelators | |
JPH09512249A (ja) | 腎臓疾患を治療するためのインスリンセンシタイザーの使用 | |
JP2009545547A5 (de) | ||
US6995152B2 (en) | Diagnosis and treatment of human kidney diseases | |
BRPI0606805A2 (pt) | kit, e, unidade de dosagem | |
BR112015012497B1 (pt) | Combinações e composições farmacêuticas, seus usos, preparação combinada, e embalagem comercial | |
WO2019067771A1 (en) | COMPOSITIONS AND METHODS FOR TREATING SEPTIC CARDIOMYOPATHY | |
KR20100016512A (ko) | 심근경색증 치료를 위한 철 킬레이터의 용도 | |
TWI777059B (zh) | 肌肉減少症之預防劑及治療劑 | |
Atessahin et al. | Effects of therapeutic and toxic doses of levamisole on thyroid hormones and some biochemical parameters in sheep |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 5A E 6A ANUIDADES. |
|
B08I | Application fees: publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2260 DE 29/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A, 9A, 10A, 11A, 12A E 13A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |